Sign for Notice Everyday    Sign Up| Sign In| Link| English|

Our Sponsors

    Receive Latest News

    Feedburner
    Share Us


    European Union Device Regulation (EU MDR)

    View: 192

    Website https://worldcomplianceseminars.com/upcoming_webinar | Want to Edit it Edit Freely

    Category Imports, exports, business, Accounts, law

    Deadline: February 20, 2020 | Date: February 20, 2020

    Venue/Country: U.S.A

    Updated: 2020-01-04 19:05:05 (GMT+9)

    Call For Papers - CFP

    The EU MDR replaces the MDD and expands the requirements for conformance

    The EU MDR will be effective in May 2020. Products intended to be imported into the EU must conform to these new regulations. Arrangements must be made with a Notified Body, an Authorized Representative and a Person Responsible for Regulatory Compliance. There is extensive preparation necessary. This webinar will explain what needs to be done to meet the deadline

    Session Highlights:

    • EU MDR objectives

    • QMS requirements

    • Device classification changes

    • Documentation requirements

    • Clinical evaluation requirements

    • UDI and labelling requirements

    • Post market surveillance

    • New Notified Body obligations

    • Human Factors/ Usability requirements

    Speaker:

    Edwin Waldbusser is a consultant retired from industry after 20 years in management of development of medical devices (5 patents). He has been consulting in the US and internationally in the areas of design control, risk analysis and software validation for the past 10 years.


    Keywords: Accepted papers list. Acceptance Rate. EI Compendex. Engineering Index. ISTP index. ISI index. Impact Factor.
    Disclaimer: ourGlocal is an open academical resource system, which anyone can edit or update. Usually, journal information updated by us, journal managers or others. So the information is old or wrong now. Specially, impact factor is changing every year. Even it was correct when updated, it may have been changed now. So please go to Thomson Reuters to confirm latest value about Journal impact factor.